Clinical Trial Update: Study of BCMA CAR-T in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for a BCMA CAR-T therapy in multiple myeloma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA CAR-T

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN